BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment

  February 3, 2026

   · 

  8 min read
• Press Releases

  Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems

  February 3, 2026

   · 

  6 min read
• Press Releases

  TSC Life Receives FDA Clearance for Pediatric Use with Fluido® Compact System, a Blood & Fluid Warmer, in the U.S. and Canada

  February 3, 2026

   · 

  3 min read
• Press Releases

  Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

  February 3, 2026

   · 

  4 min read
• Press Releases

  Ardelyx Receives New Patent for Tenapanor

  February 3, 2026

   · 

  6 min read
• Press Releases

  Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

  February 3, 2026

   · 

  10 min read
• Press Releases

  aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

  February 3, 2026

   · 

  5 min read
• Press Releases

  Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer

  February 3, 2026

   · 

  6 min read
• Press Releases

  Byonyks X1: Revolutinizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.

  February 3, 2026

   · 

  3 min read
• Press Releases

  Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026

  February 3, 2026

   · 

  1 min read